Asiatic acid inhibits pro-angiogenic effects of VEGF and human gliomas in endothelial cell culture models

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Kavitha, Chandagirikoppal V ^a   Agarwal, Chapla ^a,b   Agarwal, Rajesh ^a,b   Deep, Gagan ^a,b  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASIATIC ACID; CASPASE 3; CASPASE 9; PROTEIN BAD; SURVIVIN; VASCULOTROPIN; ANGIOGENESIS INHIBITOR; PENTACYCLIC TRITERPENE; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; ENZYME ACTIVATION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TREATMENT OUTCOME; UMBILICAL VEIN ENDOTHELIAL CELL; CELL CULTURE; CELL MOTION; CELL SURVIVAL; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; TUMOR CELL LINE; WESTERN BLOTTING;

ANGIOGENESIS INHIBITORS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; ENDOTHELIAL CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLIOMA; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; PENTACYCLIC TRITERPENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79961083687     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022745     Document Type: Article

References (52)

1. Skobe M, Rockwell P, Goldstein N, Vosseler S, Fusenig NE, (1997) Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 3: 1222-1227.
2. Folkman J, (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1: 27-31.
3. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. cell 100: 57-70.
4. Fan S, Sun Z, Jiang D, Dai C, Ma Y, et al. (2009) BmKCT toxin inhibits glioma proliferation and tumor metastasis. Cancer Lett 291: 158-166.
5. Takano S, Yamashita T, Ohneda O, (2010) Molecular therapeutic targets for glioma angiogenesis. J Oncol 2010.
6. Louis DN, Pomeroy SL, Cairncross JG, (2002) Focus on central nervous system neoplasia. Cancer Cell 1: 125-128.
7. Giese A, Bjerkvig R, Berens ME, Westphal M, (2003) Cost of migration: invasion of malignant gliomas and implications for treatment. J Clin Oncol 21: 1624-1636.
8. Preusser M, Haberler C, Hainfellner JA, (2006) Malignant glioma: neuropathology and neurobiology. Wien Med Wochenschr 156: 332-337.
9. Omuro AM, Faivre S, Raymond E, (2007) Lessons learned in the development of targeted therapy for malignant gliomas. Mol Cancer Ther 6: 1909-1919.
10. Takano S, Kamiyama H, Mashiko R, Osuka S, Ishikawa E, et al. (2010) Metronomic treatment of malignant glioma xenografts with irinotecan (CPT-11) inhibits angiogenesis and tumor growth. J Neurooncol 99: 177-185.
11. Onishi M, Ichikawa T, Kurozumi K, Date I Angiogenesis and invasion in glioma. Brain Tumor Pathol 28: 13-24.
12. Jain RK, di Tomaso E, Duda DG, Loeffler JS, Sorensen AG, et al. (2007) Angiogenesis in brain tumours. Nat Rev Neurosci 8: 610-622.
13. Ferrara N, Gerber HP, LeCouter J, (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676.
14. Breen EC, (2007) VEGF in biological control. J Cell Biochem 102: 1358-1367.
15. Gu Q, Wang D, Wang X, Peng R, Liu J, et al. (2004) Basic fibroblast growth factor inhibits radiation-induced apoptosis of HUVECs. I. The PI3K/AKT pathway and induction of phosphorylation of BAD. Radiat Res 161: 692-702.
16. Gingis-Velitski S, Zetser A, Flugelman MY, Vlodavsky I, Ilan N, (2004) Heparanase induces endothelial cell migration via protein kinase B/Akt activation. J Biol Chem 279: 23536-23541.
17. Gerber HP, McMurtrey A, Kowalski J, Yan M, Keyt BA, et al. (1998) Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation. J Biol Chem 273: 30336-30343.
18. Tortora G, Melisi D, Ciardiello F, (2004) Angiogenesis: a target for cancer therapy. Curr Pharm Des 10: 11-26.
19. Zhong H, Bowen JP, (2007) Molecular design and clinical development of VEGFR kinase inhibitors. Curr Top Med Chem 7: 1379-1393.
20. Kabbinavar F, Hurwitz HI, Fehrenbacher L, Meropol NJ, Novotny WF, et al. (2003) Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 21: 60-65.
21. Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, et al. (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350: 2335-2342.
22. Kreisl TN, Kim L, Moore K, Duic P, Royce C, et al. (2009) Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma. J Clin Oncol 27: 740-745.
23. Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, et al. (2009) Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma. J Clin Oncol 27: 4733-4740.
24. Junck L Bevacizumab antiangiogenic therapy for glioblastoma. Neurology 76: 414-415.
25. Soo Lee Y, Jin DQ, Beak SM, Lee ES, Kim JA, (2003) Inhibition of ultraviolet-A-modulated signaling pathways by asiatic acid and ursolic acid in HaCaT human keratinocytes. Eur J Pharmacol 476: 173-178.
26. Tang XL, Yang XY, Jung HJ, Kim SY, Jung SY, et al. (2009) Asiatic acid induces colon cancer cell growth inhibition and apoptosis through mitochondrial death cascade. Biol Pharm Bull 32: 1399-1405.
27. Hsu YL, Kuo PL, Lin LT, Lin CC, (2005) Asiatic acid, a triterpene, induces apoptosis and cell cycle arrest through activation of extracellular signal-regulated kinase and p38 mitogen-activated protein kinase pathways in human breast cancer cells. J Pharmacol Exp Ther 313: 333-344.
28. Gurfinkel DM, Chow S, Hurren R, Gronda M, Henderson C, et al. (2006) Disruption of the endoplasmic reticulum and increases in cytoplasmic calcium are early events in cell death induced by the natural triterpenoid Asiatic acid. Apoptosis 11: 1463-1471.
29. Park BC, Paek SH, Lee YS, Kim SJ, Lee ES, et al. (2007) Inhibitory effects of asiatic acid on 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol 13-acetate-induced tumor promotion in mice. Biol Pharm Bull 30: 176-179.
30. Krishnamurthy RG, Senut MC, Zemke D, Min J, Frenkel MB, et al. (2009) Asiatic acid, a pentacyclic triterpene from Centella asiatica, is neuroprotective in a mouse model of focal cerebral ischemia. J Neurosci Res 87: 2541-2550.
31. Lee YS, Jin DQ, Kwon EJ, Park SH, Lee ES, et al. (2002) Asiatic acid, a triterpene, induces apoptosis through intracellular Ca2+ release and enhanced expression of p53 in HepG2 human hepatoma cells. Cancer Lett 186: 83-91.
32. Cho CW, Choi DS, Cardone MH, Kim CW, Sinskey AJ, et al. (2006) Glioblastoma cell death induced by asiatic acid. Cell Biol Toxicol 22: 393-408.
33. Park BC, Bosire KO, Lee ES, Lee YS, Kim JA, (2005) Asiatic acid induces apoptosis in SK-MEL-2 human melanoma cells. Cancer Lett 218: 81-90.
34. Bunpo P, Kataoka K, Arimochi H, Nakayama H, Kuwahara T, et al. (2005) Inhibitory effects of asiatic acid and CPT-11 on growth of HT-29 cells. J Med Invest 52: 65-73.
35. Bunpo P, Kataoka K, Arimochi H, Nakayama H, Kuwahara T, et al. (2004) Inhibitory effects of Centella asiatica on azoxymethane-induced aberrant crypt focus formation and carcinogenesis in the intestines of F344 rats. Food Chem Toxicol 42: 1987-1997.
36. Whitacre CM, Berger NA, (1997) Factors affecting topotecan-induced programmed cell death: adhesion protects cells from apoptosis and impairs cleavage of poly(ADP-ribose)polymerase. Cancer Res 57: 2157-2163.
37. van Moorselaar RJ, Voest EE, (2002) Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches. Mol Cell Endocrinol 197: 239-250.
38. Patan S, (2004) Vasculogenesis and angiogenesis. Cancer Treat Res 117: 3-32.
39. Saunders WB, Bohnsack BL, Faske JB, Anthis NJ, Bayless KJ, et al. (2006) Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3. J Cell Biol 175: 179-191.
40. Singh RH, Narsimhamurthy K, Singh G, (2008) Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology 9: 369-374.
41. Mato L, Wattanathorn J, Muchimapura S, Tongun T, Piyawatkul N, et al. (2009) Centella asiatica Improves Physical Performance and Health-related Quality of Life in Healthy Elderly Volunteer. Evid Based Complement Alternat Med.
42. Dhanasekaran M, Holcomb LA, Hitt AR, Tharakan B, Porter JW, et al. (2009) Centella asiatica extract selectively decreases amyloid beta levels in hippocampus of Alzheimer's disease animal model. Phytother Res 23: 14-19.
43. Shinomol GK, Muralidhara, (2008) Prophylactic neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of prepubertal mice. Neurotoxicology 29: 948-957.
44. Shinomol GK, Ravikumar H Prophylaxis with Centella asiatica confers protection to prepubertal mice against 3-nitropropionic-acid-induced oxidative stress in brain. Phytother Res 24: 885-892.
45. Grimaldi R, De Ponti F, D'Angelo L, Caravaggi M, Guidi G, et al. (1990) Pharmacokinetics of the total triterpenic fraction of Centella asiatica after single and multiple administrations to healthy volunteers. A new assay for asiatic acid. J Ethnopharmacol 28: 235-241.
46. Albini A, Sporn MB, (2007) The tumour microenvironment as a target for chemoprevention. Nat Rev Cancer 7: 139-147.
47. Singh RP, Dhanalakshmi S, Agarwal C, Agarwal R, (2005) Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy. Oncogene 24: 1188-1202.
48. Boehm T, Folkman J, Browder T, O'Reilly MS, (1997) Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 390: 404-407.
49. Carmeliet P, Jain RK, (2000) Angiogenesis in cancer and other diseases. Nature 407: 249-257.
50. Khwaja A, (1999) Akt is more than just a Bad kinase. Nature 401: 33-34.
51. Zhao P, Meng Q, Liu LZ, You YP, Liu N, et al. (2010) Regulation of survivin by PI3K/Akt/p70S6K1 pathway. Biochem Biophys Res Commun 395: 219-224.
52. Agarwal C, Singh RP, Dhanalakshmi S, Tyagi AK, Tecklenburg M, et al. (2003) Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Oncogene 22: 8271-8282.